Targeting the TGF-β signaling pathway for fibrosis therapy: a patent review (2015–2020)
-
- Xuanyi Li
- Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, China
-
- Ziang Ding
- Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, China
-
- Zixuan Wu
- Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, China
-
- Yinqiu Xu
- Department of Pharmacy, Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital, Nanjing, China
-
- Hequan Yao
- Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, China
-
- Kejiang Lin
- Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, China
Journal
-
- Expert Opinion on Therapeutic Patents
-
Expert Opinion on Therapeutic Patents 31 (8), 723-743, 2021-05-17
Informa UK Limited
- Tweet
Details 詳細情報について
-
- CRID
- 1360579817460134784
-
- ISSN
- 17447674
- 13543776
-
- Data Source
-
- Crossref